STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Completed
- T-cell Acute Lymphoblastic Leukemia/Lymphoma
- CD7 CAR-T
- Yanda, Hebei, ChinaHebei yanda Ludaopei Hospital
2021-06-23
Jun 23, 2021M
Recruiting
- T Acute Lymphoblastic Leukemia
- T-lymphoblastic Lymphoma
- RD13-01 cell infusion
- Langfang, Hebei, ChinaHebei Yanda Ludaopei Hospital
2020-11-03
Nov 3, 2020F
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021S
Not yet recruiting
- Pediatric ALL, B Cell
- Minimal Residual Disease
- Blinatumomab for Injection
- (no location specified)
2021-04-09
Apr 9, 2021W
Not yet recruiting
- T-cell Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- WU-CART-007
- (no location specified)
2021-09-16
Sep 16, 2021i
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- +2 more
- CD7 CAR T cells
- Shenzhen, Guangdong, ChinaPeking University Shenzhen Hospital
2021-06-19
Jun 19, 2021U
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Diagnosis of and treatment for Acute lymphoblastic leukaemia in childhood
- Aarhus C, DenmarkDepartment of Public Health
2020-12-01
Dec 1, 2020N
Not yet recruiting
- T-cell Acute Lymphoblastic Leukemia
- T-Cell Acute Lymphoblastic Lymphoma
- (no location specified)
2021-07-13
Jul 13, 2021i
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- T-cell Non-Hodgkin Lymphoma
- anti-CD5 CAR T cells
- Shenzhen, Guangdong, ChinaPeking University Shenzhen Hospital
2021-02-27
Feb 27, 2021A
Active, not recruiting
- Acute Lymphoblastic Leukemia, Adult B-Cell
- Blinatumomab Injection
- Paris, FranceHopital saint Louis
2021-04-30
Apr 30, 2021E
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- XmAb18968 - Dose level -1
- +4 more
- Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
2021-11-10
Nov 10, 2021U
Withdrawn
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Surveys and Questionnaires
- Questionnaires
- Aarhus, Aarhus N, DenmarkKaren Schow Jensen
2020-09-03
Sep 3, 2020F
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- dasatinib plus consolidation chemotherapy with vincristine and prednisone
- dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
- Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021P
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Inotuzumab Ozogamicin
- Bristol, United Kingdom
- +3 more
2021-09-08
Sep 8, 2021C
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Electronic Health Record Review
- +2 more
- (no location specified)
2021-11-17
Nov 17, 2021B
Recruiting
- T-Cell Acute Lymphoblastic Leukemia
- CD5 CART
- Beijing, Beijing, ChinaBeijing Boren Hospital
2021-11-03
Nov 3, 2021U
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Recurrence
- Mode of relapse/SMN detection
- Aarhus N, Denmark
- +4 more
2021-08-31
Aug 31, 2021N
Recruiting
- Leukemia, Acute Lymphoblastic
- Acute Lymphobastic Leukemia (ALL) Treatment Options
- Albuquerque, New MexicoUniversity of New Mexico Comprehensive Cancer Center
2021-05-11
May 11, 2021S
Recruiting
- MRD-positive
- Acute Lymphoblastic Leukemia
- anti-CD19/CD22 CAR-T cells
- +2 more
- Shanghai, Shanghai, ChinaShanghai General Hospital
2021-09-23
Sep 23, 2021M
Active, not recruiting
- Leukemia
- Acute Lymphoblastic Leukemia
- gene-modified T cells targeted
- New York, New YorkMemorial Sloan Kettering Cancer Center
2021-02-01
Feb 1, 20219
Recruiting
- B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoma
- anti-CD19 UCAR-T injection
- Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
2021-10-25
Oct 25, 2021A
Recruiting
- Acute Lymphoblastic Leukemia
- CAR-T cells
- Beijing, ChinaDepartment of Hematopoietic Stem Cell Transplantation
2021-02-06
Feb 6, 2021U
Recruiting
- Acute Lymphoblastic Leukemia
- Biospecimen Collection
- Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
2021-11-16
Nov 16, 2021F
C
Recruiting
- Peripheral Blood Stem Cell Transplantation
- Modified By/Cy conditioning regimen intensified by Ruxolitinib and Chidamide
- Beijing, Beijing, ChinaChinese PLA General Hospital
2021-09-29
Sep 29, 2021